Syros Pharmaceuticals Current Assets

Syros Pharmaceuticals (SYRS) currently reports a current assets of $64M as of September 2024. That compares with $120M in the prior-year period — down 47.8% year over year. Use the charts on this page to explore Syros Pharmaceuticals's current assets history and peer comparisons.

Syros Pharmaceuticals's current assets decreased from $120M to $64M — a 47.8% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Syros Pharmaceuticals reported $64M in current assets as of September 2024. That compares with $120M in the prior-year period — down 47.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $64M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Syros Pharmaceuticals, and consider following SYRS for alerts when major investors trade the stock.

Syros Pharmaceuticals is classified in the Healthcare sector. On current assets, it currently shows $64M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SYRS with unrelated industries.